Humana Inc.
HUMHealthcareNASDAQHealthcare Plans
Scan Results
Daily timeframePart of the healthcare sector, Humana Inc. (HUM) is listed under Healthcare Plans. At a $50.68B market cap, Humana Inc. ranks as a large-cap company within healthcare. It operates in two segments, Insurance and CenterWell.
Market Cap
$50.68B
Beta
0.74
P/E (TTM)
39.89
P/E (Fwd)
24.70
EPS (TTM)
$10.58
EPS (Fwd)
$17.09
ROE
6.9%
ROA
3.9%
Cash
$23.87B
Total Debt
$14.74B
Free CF
$1.94B
52W Change
44.4%
Annual Financials
Cash vs Debt
Where HUM stands vs its 150-day and 200-day moving averages
As of the October 13, 2026 close, HUM finished 34.28% above its 150-day moving average ($322.83) and 45.93% above its 200-day moving average ($297.07). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is HUM overbought or oversold?
At the October 13, 2026 close, HUM's RSI(14) was 73.2, in overbought territory (above 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
With $23.87B in cash and $14.74B in debt, HUM maintains more liquidity than leverage. This favorable balance sheet position can be an asset when capital markets become less accommodating. Annual free cash flow of $1.94B supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. Return on equity stands at 6.9%, which is modest for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. ROA of 3.9% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $83.06B (2021) to $129.66B (2025), reflecting a 56% increase over the period.
As with any equity investment, HUM carries market risk, sector-specific risk, and company-specific risk that investors should evaluate in the context of their own portfolios. No single metric tells the full story. Reviewing HUM's risk profile alongside its fundamentals and technical indicators provides a more complete picture.